These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11834428)

  • 1. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects.
    Hanew K; Utsumi A
    Eur J Endocrinol; 2002 Feb; 146(2):197-202. PubMed ID: 11834428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K; Tanaka A; Utsumi A; Sugawara A; Abe K
    J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
    Jaffe CA; DeMott-Friberg R; Barkan AL
    J Clin Invest; 1996 Feb; 97(4):934-40. PubMed ID: 8613546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P; Knip M; Lautala P; Leppäluoto J
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
    Page MD; Dieguez C; Valcavi R; Koppeschaar HP; Scanlon MF
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):97-102. PubMed ID: 8306488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases].
    Mitsuhashi S; Yamasaki R; Miyazaki S; Saito H; Saito S
    Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):934-46. PubMed ID: 3123283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone response to growth hormone-releasing hormone (GHRH), insulin, clonidine and arginine after GHRH pretreatment in obese children: evidence of somatostatin increase?
    Volta C; Bernasconi S; Iughetti L; Ghizzoni L; Rossi M; Costa M; Cozzini A
    Eur J Endocrinol; 1995 Jun; 132(6):716-21. PubMed ID: 7788012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-induced hypoglycemia, L-dopa and arginine stimulate GH secretion through different mechanisms in man.
    Masuda A; Shibasaki T; Hotta M; Yamauchi N; Ling N; Demura H; Shizume K
    Regul Pept; 1990 Oct; 31(1):53-64. PubMed ID: 2270318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.
    Hanew K; Tanaka A; Utsumi A
    J Endocrinol Invest; 1998 Feb; 21(2):72-7. PubMed ID: 9585379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.
    Page MD; Dieguez C; Valcavi R; Edwards C; Hall R; Scanlon MF
    Clin Endocrinol (Oxf); 1988 May; 28(5):551-8. PubMed ID: 3145820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults.
    Saito H; Hosoi E; Yamasaki R; Kameyama K; Irahara M; Ohno Y; Saito S
    Horm Metab Res; 1997 Apr; 29(4):184-9. PubMed ID: 9178029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
    Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH response to GHRH, insulin, clonidine and arginine after GHRH pretreatment in children.
    Bernasconi S; Volta C; Cozzini A; Ziveri M; Ghizzoni L; Panza C; Ghigo E
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):105-8. PubMed ID: 1543013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
    Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone in obesity.
    Scacchi M; Pincelli AI; Cavagnini F
    Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood.
    Bellone J; Aimaretti G; Valetto MR; Bellone S; Baffoni C; Arvat E; Seminara S; Camanni F; Ghigo E
    Eur J Endocrinol; 1996 Oct; 135(4):421-4. PubMed ID: 8921823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.